Search


	Podcast:		BioCentury This Week
	Episode:		Ep. 341 - BioCentury's '25-'26 Picks. Plus: BioMarin & Biotech ICYMI
	Category:		Science & Medicine
	Duration:		00:38:15
	Publish Date:		2025-12-30 02:00:00
	Description:		This past year was an inflection point for biotech: The markets woke up, M&A and China had strong showings, drug development offered key trends, and new leadership at FDA shuffled the regulatory deck. On the latest BioCentury This Week podcast, BioCentury’s analysts make their picks for the biggest biopharma readouts, deals and regulatory and policy moves of 2025 and what they are forecasting for the year ahead. The analysts also recap biotech highlights of the past two weeks, including the $4.8 billion takeout of Amicus Therapeutics by BioMarin Pharmaceutical. View full story: https://www.biocentury.com/article/657933 #BiotechOutlook2026 #BiopharmaTrends #BiotechMA #FDALeadership #ChinaBiotech 00:00 - Introduction 02:31 - BioMarin's $4.8B Amicus Deal 06:07 - Year-end Biotech Highlights 16:37 - Analyst Picks and Predictions 30:01 - Policy and Regulatory Landscape To submit a question to BioCentury’s editors, email the BioCentury This Week team at podcasts@biocentury.com. Reach us by sending a text
	Total Play:		0